Multivariate clustering of progression profiles reveals different depression patterns in prodromal huntington disease

Neuropsychology

Volumn 29, Issue 6, 2015, Pages 949-960

  Kim, Ji In ^a   Long, Jeffrey D ^a,b   Mills, James A ^a   McCusker, Elizabeth ^c   Paulsen, Jane S ^a,b   De Soriano, Isabella ^b   Shadrick, Courtney ^b   Miller, Amanda ^b   Chiu, Edmond ^d   Preston, Joy ^d   Goh, Anita ^d   Antonopoulos, Stephanie ^d   Loi, Samantha ^d   Chua, Phyllis ^d   Komiti, Angela ^d   Raymond, Lynn ^e   Decolongon, Joji ^e   Fan, Mannie ^e   Coleman, Allison ^e   Ross, Christopher A ^f   Varvaris, Mark ^f   Ong, Maryjane ^f   Yoritomo, Nadine ^f   Mallonee, William M ^g   Suter, Greg ^g   Samii, Ali ^h   Freney, Emily P ^h   Macaraeg, Alma ^h   Jones, Randi ⁱ   Wood Siverio, Cathy ⁱ   Factor, Stewart A ⁱ   Barker, Roger A ^j   Mason, Sarah ^j   Guzman, Natalie Valle ^j   Griffith, Jane ^c   Loy, Clement ^c   McMillan, Jillian ^c   Gunn, David ^c   Orth, Michael ^k   Süßmuth, Sigurd ^k   Barth, Katrin ^k   Trautmann, Sonja ^k   Schwenk, Daniela ^k   Eschenbach, Carolin ^k   Quaid, Kimberly ^l   Wesson, Melissa ^l   Wojcieszek, Joanne ^l   Guttman, Mark ^m   Sheinberg, Alanna ^m   Law, Albie ^m   Karmalkar, Irita ^m   Perlman, Susan ⁿ   Clemente, Brian ⁿ   Geschwind, Michael D ^o   Sha, Sharon ^o   Winer, Joseph ^o   Satris, Gabriela ^o   Warner, Tom ^p   Burrows, Maggie ^p   Rosser, Anne ^q   Price, Kathy ^q   Hunt, Sarah ^q   Marshall, Frederick ^r   Chesire, Amy ^r   Wodarski, Mary ^r   Hickey, Charlyne ^r   Panegyres, Peter ^s   Lee, Joseph ^s   Tedesco, Maria ^s   Maxwell, Brenton ^s   Perlmutter, Joel ^t   Barton, Stacey ^t   Smith, Shineeka ^t   Miedzybrodzka, Zosia ^u   Rae, Daniela ^u   Vaughan, Vivien ^u   D'Alessandro, Mariella ^u   Craufurd, David ^v   Bek, Judith ^v   Howard, Elizabeth ^v   Mazzoni, Pietro ^w   Marder, Karen ^w   Wasserman, Paula ^w   Kumar, Rajeev ^x   Erickson, Diane ^x   Reeves, Christina ^x   Nickels, Breanna ^x   Wheelock, Vicki ^y   Kjer, Lisa ^y   Martin, Amanda ^y   Farias, Sarah ^y   Martin, Wayne ^z   Suchowersky, Oksana ^z   King, Pamela ^z   Wieler, Marguerite ^z   Sran, Satwinder ^z   Ahmed, Anwar ^aa   Rao, Stephen ^aa   Reece, Christine ^aa   Bura, Alex ^aa   Mourany, Lyla ^aa   Johnson, Hans J ^b   Brashers Krug, Thomas ^b   Danzer, Phil ^ah   Jeremy Bockholt, H ^ah   Montross, Kelsey ^ah   Harrington, Deborah ^ab   Westervelt, Holly ^ac   Aylward, Elizabeth ^ad   Moser, David J ^b   Williams, Janet ^b   Downing, Nancy ^b   Magnotta, Vincent A ^b   Vaidya, Jatin ^b   O'Leary, Daniel ^b   Kim, Eun Young ^b   Lourens, Spencer ^b   Zhang, Ying ^ae   Lu, Wenjing ^ae   Erwin, Cheryl ^af   Nance, Martha ^ag   Bockholt, H Jeremy ^b   Evans, Jason ^b   Zschiegner, Roland ^b   more..

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g Hereditary Neurological Disease Centre   (United States)

^h VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

ⁱ EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^k UNIVERSITY OF ULM   (Germany)

^l INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m UNIVERSITY OF TORONTO   (Canada)

ⁿ UCLA MEDICAL CENTER   (United States)

^o UNIVERSITY OF CALIFORNIA   (United States)

^p NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^q CARDIFF UNIVERSITY   (United Kingdom)

^r UNIVERSITY OF ROCHESTER   (United States)

^s Graylands Selby Lemnos and Special Care Health Services   (Australia)

^t UNIVERSITY OF WASHINGTON   (United States)

^u Clinical Genetics Centre   (United Kingdom)

^v UNIVERSITY OF MANCHESTER   (United Kingdom)

^w NewYork Presbyterian Hospital   (United States)

^x University of Manchester ^*  (United States)

^y UNIVERSITY OF CALIFORNIA   (United States)

^z UNIVERSITY OF ALBERTA   (Canada)

^aa LERNER RESEARCH INSTITUTE   (United States)

^ab UNIVERSITY OF CALIFORNIA   (United States)

^ac BROWN UNIVERSITY   (United States)

^ad SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^ae INDIANA UNIVERSITY   (United States)

^af TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^ag UNIVERSITY OF MINNESOTA   (United States)

^ah University of Minnesota ^*

more..

Author keywords

Cognition; Depression; Genetics; Huntington disease; Movement disorders

Indexed keywords

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GROWTH MIXTURE MODEL; HUMAN; HUNTINGTON CHOREA; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; MOTOR DYSFUNCTION; MULTIVARIATE CLUSTERING; NONBIOLOGICAL MODEL; PHENOTYPE; PREDICTIVE VALUE; PRIORITY JOURNAL; PRODROMAL HUNTINGTON DISEASE; SYMPTOM; CLASSIFICATION; CLUSTER ANALYSIS; MIDDLE AGED; PATHOPHYSIOLOGY; PRODROMAL SYMPTOM;

ADULT; CLUSTER ANALYSIS; DEPRESSION; DISEASE PROGRESSION; FEMALE; HUMANS; HUNTINGTON DISEASE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PRODROMAL SYMPTOMS;

EID: 84947026610     PISSN: 08944105     EISSN: 19311559     Source Type: Journal    
DOI: 10.1037/neu0000199     Document Type: Article

References (42)

1. Andrew, S. E., Goldberg, Y. P., Kremer, B., Telenius, H., Theilmann, J., Adam, S.,. Hayden, M. R. (1993). The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nature Genetics, 4, 398-403. http://dx.doi.org/10.1038/ng0893-398.
2. Armstrong, M. J., Miyasaki, J. M., & the American Academy of Neurology. (2012). Evidence-based guideline: Pharmacologic treatment of chorea in Huntington disease: Report of the guideline development subcommittee of the American Academy of Neurology. Neurology, 79, 597-603. http://dx.doi.org/10.1212/WNL.0b013e318263c443.
3. Barone, P., Poewe, W., Albrecht, S., Debieuvre, C., Massey, D., Rascol, O.,. Weintraub, D. (2010). Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: A randomised, double-blind, placebo-controlled trial. The Lancet Neurology, 9, 573-580. http://dx.doi.org/10.1016/S1474-4422(10)70106-X.
4. Beck, A. T., Steer, R. A., & Brown, G. W. (1996). Beck Depression Inventory-II manual. New York, NY: The Psychological Corporation.
5. Biglan, K. M., Zhang, Y., Long, J. D., Geschwind, M., Kang, G. A., Killoran, A.,. Paulsen, J. S., & the PREDICT-HD Investigators of the Huntington Study Group. (2013). Refining the diagnosis of Huntington disease: The PREDICT-HD study. Frontiers in Aging Neuroscience, 5, 12. http://dx.doi.org/10.3389/fnagi.2013.00012.
6. Celuex, G., & Soromenho, G. (1996). An entropy criterion for assessing the number of clusters in a mixture model. Journal of Classification, 13, 195-212.
7. Claes, S., Van Zand, K., Legius, E., Dom, R., Malfroid, M., Baro, F.,. Cassiman, J. J. (1995). Correlations between triplet repeat expansion and clinical features in Huntington's disease. Archives of Neurology, 52, 749-753. http://dx.doi.org/10.1001/archneur.1995.00540320021009.
8. Codori, A. M., Hanson, R., & Brandt, J. (1994). Self-selection in predictive testing for Huntington's disease. American Journal of Medical Genetics, 54, 167-173. http://dx.doi.org/10.1002/ajmg.1320540303.
9. Dempster, A. P., Laird, N. M., & Rubin, D. B. (1977). Maximum Likelihood from Incomplete Data via the EM Algorithm. Journal of the Royal Statistical Society, Series B, 39, 1-38.
10. De Souza, J., Jones, L. A., & Rickards, H. (2010). Validation of self-report depression rating scales in Huntington's disease. Movement Disorders, 25, 91-96. http://dx.doi.org/10.1002/mds.22837.
11. Downing, N. R., Kim, J.-I., Williams, J. K., Long, J. D., Mills, J. A., & Paulsen, J. S., & the PREDICT-HD Investigators and Coordinators of the Huntington Study Group. (2014). WHODAS 2.0 in prodromal Huntington disease: Measures of functioning in neuropsychiatric disease. European Journal of Human Genetics, 22, 958-963. http://dx.doi.org/10.1038/ejhg.2013.275.
12. Duff, K., Paulsen, J. S., Beglinger, L. J., Langbehn, D. R., Wang, C., Stout, J. C.,. Queller, S., & the Predict-HD Investigators of the Huntington Study Group. (2010). "Frontal" behaviors before the diagnosis of Huntington's disease and their relationship to markers of disease progression: Evidence of early lack of awareness. The Journal of Neuropsychiatry and Clinical Neurosciences, 22, 196-207.
13. Epping, E. A., Mills, J. A., Beglinger, L. J., Fiedorowicz, J. G., Craufurd, D., Smith, M. M.,. Paulsen, J. S., & the PREDICT-HD Investigators and Coordinators of the Huntington Study Group. (2013). Characterization of depression in prodromal Huntington disease in the neurobiological predictors of HD (PREDICT-HD) study. Journal of Psychiatric Research, 47, 1423-1431. http://dx.doi.org/10.1016/j.jpsychires.2013.05.026.
14. Hardy, A. (1996). On the number of clusters. Computational Statistics & Data Analysis, 23, 83-96. http://dx.doi.org/10.1016/S0167-9473(96)00022-9.
15. Heggeseth, B. C., Jewell, N. P. (2013). The impact of covariance misspecification in multivariate Gaussian mixtures on estimation and inference: an application to longitudinal modeling. Statistics in Medicine, 32, 2790-2803.
16. Huntington Study Group. (1996). Unified Huntington's Disease Rating Scale: Reliability and consistency. Movement Disorders, 11, 136-142. http://dx.doi.org/10.1002/mds.870110204.
17. Kim, J.-I., Long, J. D., Mills, J. A., Downing, N., Williams, J. K., & Paulsen, J. S., & the PREDICT-HD Investigators and Coordinators of the Huntington Study Group. (in press). Performance of the 12-item WHODAS 2.0 in prodromal Huntington disease. European Journal of Human Genetics.
18. Langbehn, D. R., Brinkman, R. R., Falush, D., Paulsen, J. S., & Hayden, M. R., & the International Huntington's Disease Collaborative Group. (2004). A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clinical Genetics, 65, 267-277. http://dx.doi.org/10.1111/j.1399-0004.2004.00241.x.
19. Long, J. D., Paulsen, J. S., Marder, K., Zhang, Y., Kim, J.-I., & Mills, J. A., & the Researchers of the PREDICT-HD Huntington's Study Group. (2014). Tracking motor impairments in the progression of Huntington's disease. Movement Disorders, 29, 311-319. http://dx.doi.org/10.1002/mds.25657.
20. MacDonald, M., & The Huntington's Disease Collaborative Research Group. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell, 72, 971-983. http://dx.doi.org/10.1016/0092-8674(93)90585-E.
21. Magidson, J., & Vermunt, J. (2004). Latent class models. In D. Kaplan (Ed.), Handbook of quantitative methodology for the social sciences (pp. 176-198). Newbury Park, CA: Sage. http://dx.doi.org/10.4135/9781412986311.n10.
22. McIntosh, C. N. (2013). Pitfalls in subgroup analysis based on growth mixture models: A commentary on Van Leeuwen et al. (2012). Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care & Rehabilitation, 22, 2625-2629. http://dx.doi.org/10.1007/s11136-013-0385-x.
23. Muthén, B., & Muthén, L. K. (2000). Integrating person-centered and variable-centered analyses: Growth mixture modeling with latent trajectory classes. Alcoholism: Clinical and Experimental Research, 24, 882-891. http://dx.doi.org/10.1111/j.1530-0277.2000.tb02070.x.
24. Nehl, C., Ready, R. E., Hamilton, J., & Paulsen, J. S. (2001). Effects of depression on working memory in presymptomatic Huntington's dis ease. The Journal of Neuropsychiatry and Clinical Neurosciences, 13, 342-346. http://dx.doi.org/10.1176/jnp.13.3.342.
25. Ossig, C., & Storch, A. (2015). Depression in Huntington's Disease. In H. Reichmann (Ed.), Neuropsychiatric Symptoms of Movement Disorders (pp. 201-209). Switzerland: Springer. http://dx.doi.org/10.1007/978-3-319-09537-0_9.
26. Paulsen, J. S., Hayden, M., Stout, J. C., Langbehn, D. R., Aylward, E., Ross, C. A.,. Penziner, E., & the Predict-HD Investigators of the Huntington Study Group. (2006). Preparing for preventive clinical trials: The Predict-HD study. Archives of Neurology, 63, 883-890. http://dx.doi.org/10.1001/archneur.63.6.883.
27. Paulsen, J. S., Langbehn, D. R., Stout, J. C., Aylward, E., Ross, C. A., Nance, M.,. Hayden, M., & the Predict-HD Investigators and Coordinators of the Huntington Study Group. (2008). Detection of Huntington's disease decades before diagnosis: The Predict-HD study. Journal of Neurology, Neurosurgery & Psychiatry, 79, 874-880. http://dx.doi.org/10.1136/jnnp.2007.128728.
28. Paulsen, J. S., & Long, J. D. (2012). Neurodegenerative disease: Establishing a clinical trial battery for Huntington disease. Nature Reviews. Neurology, 8, 250-251. http://dx.doi.org/10.1038/nrneurol.2012.67.
29. Paulsen, J. S., Long, J. D., Johnson, H. J., Aylward, E. H., Ross, C. A., Williams, J. K.,. Panegyres, P. K., & the PREDICT-HD Investigators and Coordinators of the Huntington Study Group. (2014). Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD Study. Frontiers in Aging Neuroscience, 6, 78. http://dx.doi.org/10.3389/fnagi.2014.00078.
30. Paulsen, J. S., Long, J. D., Ross, C. A., Harrington, D. L., Erwin, C. J., Williams, J. K.,. Barker, R. A., & the PREDICT-HD Investigators and Coordinators of the Huntington Study Group. (2014). Prediction of manifest Huntington's disease with clinical and imaging measures: A prospective observational study. The Lancet Neurology, 13, 1193-1201. http://dx.doi.org/10.1016/S1474-4422(14)70238-8.
31. Paulsen, J. S., Nehl, C., Hoth, K. F., Kanz, J. E., Benjamin, M., Conybeare, R.,. Turner, B. (2005). Depression and stages of Huntington's disease. The Journal of Neuropsychiatry and Clinical Neurosciences, 17, 496-502.
32. Paulsen, J. S., Smith, M. M., & Long, J. D., & the PREDICT HD Investigators and Coordinators of the Huntington Study Group. (2013). Cognitive decline in prodromal Huntington Disease: Implications for clinical trials. Journal of Neurology, Neurosurgery, and Psychiatry, 84, 1233-1239. http://dx.doi.org/10.1136/jnnp-2013-305114.
33. Penney, J. B., Jr., Vonsattel, J. P., MacDonald, M. E., Gusella, J. F., & Myers, R. H. (1997). CAG repeat number governs the development rate of pathology in Huntington's disease. Annals of Neurology, 41, 689-692. http://dx.doi.org/10.1002/ana.410410521.
34. Rosenblatt, A., Kumar, B. V., Mo, A., Welsh, C. S., Margolis, R. L., & Ross, C. A. (2012). Age, CAG repeat length, and clinical progression in Huntington's disease. Movement Disorders, 27, 272-276. http://dx.doi.org/10.1002/mds.24024.
35. Ross, C. A., Aylward, E. H., Wild, E. J., Langbehn, D. R., Long, J. D., Warner, J. H.,. Tabrizi, S. J. (2014). Huntington disease: Natural history, biomarkers and prospects for therapeutics. Nature Reviews Neurology, 10, 204-216. http://dx.doi.org/10.1038/nrneurol.2014.24.
36. Smith, A. (1982). Symbol Digit Modalities Test: Manual. Torrance, CA: Western Psychological Services.
37. Smith, M. M., Mills, J. A., Epping, E. A., Westervelt, H. J., & Paulsen, J. S., & the PREDICT-HD Investigators of the Huntington Study Group. (2012). Depressive symptom severity is related to poorer cognitive performance in prodromal Huntington disease. Neuropsychology, 26, 664-669. http://dx.doi.org/10.1037/a0029218.
38. Stout, J. C., Jones, R., Labuschagne, I., O'Regan, A. M., Say, M. J., Dumas, E. M.,. Frost, C. (2012). Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease. Journal of Neurology, Neurosurgery & Psychiatry, 83, 687-694. http://dx.doi.org/10.1136/jnnp-2011-301940.
39. Tabrizi, S. J., Langbehn, D. R., Leavitt, B. R., Roos, R. A., Durr, A., Craufurd, D.,. Stout, J. C., & the TRACK-HD investigators. (2009). Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: Cross-sectional analysis of baseline data. The Lancet Neurology, 8, 791-801.
40. Tabrizi, S. J., Scahill, R. I., Owen, G., Durr, A., Leavitt, B. R., Roos, R. A.,. Langbehn, D. R., & the TRACK-HD Investigators. (2013). Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: Analysis of 36-month observational data. The Lancet Neurology, 12, 637-649. http://dx.doi.org/10.1016/S1474-4422(13)70088-7.
41. Tyagi, S. N., Tyagi, L. K., Shekhar, R., Singh, M., & Kori, M. L. (2010). Symptomatic Treatment and Management of Huntington's Disease: An Overview. Global Journal of Pharmacology, 4, 6-12.
42. Zhang, Y., Long, J. D., Mills, J. A., Warner, J. H., Lu, W., & Paulsen, J. S., & the PREDICT-HD Investigators and Coordinators of the Huntington Study Group. (2011). Indexing disease progression at study entry with individuals at-risk for Huntington disease. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics: the official publication of the International Society of Psychiatric Genetics, 156, 751-763. http://dx.doi.org/10.1002/ajmg.b.31232.